Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study
- PMID: 38173815
- PMCID: PMC10763308
- DOI: 10.3389/fcvm.2023.1295174
Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study
Abstract
Objectives: To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort.
Methods: IBERICAN is an ongoing prospective cohort study, whose primary objective is to determine the frequency, incidence, and distribution of CVRF in the adult Spanish population seen in primary care settings. This analysis shows the baseline clinical characteristics of patients with hypertension. Adequate BP control was defined as BP <140/90 mmHg according to 2013 ESH/ESC guidelines.
Results: A total of 8,066 patients were consecutively included, of whom 3,860 (48.0%) had hypertension. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 years; p < 0.001), had more cardiovascular risk factors, target organ damage and cardiovascular disease (CVD) in comparison with those without hypertension. The risk of hypertension increased with the presence of associated CV risk factors and comorbidities, particularly diabetes, obesity and the metabolic syndrome, and decreased with the intensity of physical activity. Regarding antihypertensive treatments, 6.1% of patients did not take any medication, 38.8% were taking one antihypertensive drug, 35.5% two drugs, and 19.6% three or more antihypertensive drugs. Overall, 58.3% achieved BP goals <140/90 mmHg. A greater probability of BP control was observed with increasing age of patients and the greater number of antihypertensive drugs. Blood pressure control was lower in hypertensive patients with diabetes, obesity, the metabolic syndrome, increased urinary albumin excretion, higher pulse pressure, and lack of antihypertensive treatment.
Conclusions: About half of patients attended in primary care settings have hypertension in Spain. Patients with hypertension have a worse CV clinical profile than non-hypertensive patients, with greater association of CVRF and CVD. Around four out of ten patients do not achieve the recommended BP goals, and higher use of combination therapies is associated with a better BP control.
Keywords: blood pressure; cardiovascular risk; combined therapy; hypertension; primary care.
© 2023 Prieto-Díaz, Pallares-Carratala, Manuel Micó-Pérez, Escobar-Cervantes, Martín-Sanchez, Coca, Barquilla-García, Velilla-Zancada, Polo-García, Segura-Fragoso, Ginel-Mendoza, Hermida-Ameijerias, Cinza-Sanjurjo and the Investigators of the IBERICAN study and of the Spanish Society of Primary Care Physicians SEMERGEN Foundation.
Conflict of interest statement
The SEMERGEN Foundation has received grants from Astra Zeneca and Menarini, but none of these grants were dedicated to financing any article of the IBERICAN study, including this article. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension.High Blood Press Cardiovasc Prev. 2020 Feb;27(1):51-59. doi: 10.1007/s40292-020-00359-0. Epub 2020 Jan 8. High Blood Press Cardiovasc Prev. 2020. PMID: 31916207
-
[Baseline clinical characteristics and management of patients included in IBERICAN study].Semergen. 2015 Jan-Feb;41(1):3-12. doi: 10.1016/j.semerg.2014.09.010. Epub 2014 Oct 16. Semergen. 2015. PMID: 25459384 Spanish.
-
Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.J Hypertens. 2019 Jul;37(7):1393-1400. doi: 10.1097/HJH.0000000000002065. J Hypertens. 2019. PMID: 31145710
-
Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.J Hum Hypertens. 1999 Sep;13(9):569-92. doi: 10.1038/sj.jhh.1000917. J Hum Hypertens. 1999. PMID: 10482967 Review.
-
Treatment of Hypertension: Which Goal for Which Patient?Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97. Adv Exp Med Biol. 2017. PMID: 27722961 Review.
Cited by
-
[Cardiovascular preventive recommendations. PAPPS 2024 thematic updates].Aten Primaria. 2024 Nov;56 Suppl 1(Suppl 1):103123. doi: 10.1016/j.aprim.2024.103123. Aten Primaria. 2024. PMID: 39613355 Free PMC article. Spanish.
References
-
- Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. (2021) 397:1625–36. 10.1016/S0140-6736(21)00590-0 - DOI - PMC - PubMed
-
- Blood Pressure Lowering Treatment Trialists’ Collaboration. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet. (2021) 398:1053–64. 10.1016/S0140-6736(21)01921-8 - DOI - PMC - PubMed
-
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. (2021) 398:957–80. 10.1016/S0140-6736(21)01330-1 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources